These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34866841)

  • 21. LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.
    Min JH; Lee MW; Rhim H; Han S; Song KD; Kang TW; Jeong WK; Cha DI; Kim JM; Choi GS; Kim K
    Eur Radiol; 2024 Jan; 34(1):525-537. PubMed ID: 37526668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver transplantation?
    Huang J; Yan L; Wu H; Yang J; Liao M; Zeng Y
    J Surg Res; 2016 Jan; 200(1):122-30. PubMed ID: 26277218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma conforming to the Milan criteria: systemic review and meta-analysis.
    Yi HM; Zhang W; Ai X; Li KY; Deng YB
    Int J Clin Exp Med; 2014; 7(10):3150-63. PubMed ID: 25419346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
    Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of repeated surgical resection and radiofrequency ablation for small recurrent hepatocellular carcinoma after primary resection.
    Sun WC; Chen IS; Liang HL; Tsai CC; Chen YC; Wang BW; Lin HS; Chan HH; Hsu PI; Tsai WL; Cheng JS
    Oncotarget; 2017 Nov; 8(61):104571-104581. PubMed ID: 29262662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of clinical outcomes of radiofrequency ablation and surgical resection for hepatocellular carcinoma conforming to the Milan criteria: A systematic review and meta-analysis of recent randomized controlled trials.
    Jia Z; Zhang H; Li N
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1769-1777. PubMed ID: 33569810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma.
    Kutlu OC; Chan JA; Aloia TA; Chun YS; Kaseb AO; Passot G; Yamashita S; Vauthey JN; Conrad C
    Cancer; 2017 May; 123(10):1817-1827. PubMed ID: 28085184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy.
    Yamagishi S; Midorikawa Y; Nakayama H; Higaki T; Moriguchi M; Aramaki O; Yamazaki S; Tsuji S; Takayama T
    Hepatol Res; 2019 Apr; 49(4):432-440. PubMed ID: 30497106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of radiofrequency ablation in the treatment of small hepatocellular carcinoma.
    Zhang YJ; Chen MS
    World J Hepatol; 2010 Apr; 2(4):146-50. PubMed ID: 21160987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies.
    Kariyama K; Nouso K; Wakuta A; Oonishi A; Toyoda H; Tada T; Hiraoka A; Tsuji K; Itobayashi E; Ishikawa T; Takaguchi K; Tsutsui A; Shimada N; Kumada T
    Liver Cancer; 2020 Jan; 9(1):41-49. PubMed ID: 32071908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical resection for hepatocellular carcinoma with portal vein tumor thrombus in the Asia-Pacific region beyond the Barcelona Clinic Liver Cancer treatment algorithms: a review and update.
    Ye JZ; Wang YY; Bai T; Chen J; Xiang BD; Wu FX; Li LQ
    Oncotarget; 2017 Nov; 8(54):93258-93278. PubMed ID: 29190996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Living donor liver transplantation should be cautiously considered as initial treatment in recurrent hepatocellular carcinoma within the Milan criteria after curative liver resection.
    Kim JM; Joh JW; Yi NJ; Choi GS; Kwon CHD; Lee KW; Suh KS
    Ann Transl Med; 2020 Mar; 8(6):288. PubMed ID: 32355732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of 2 curative treatment options for very early hepatocellular carcinoma: Efficacy, recurrence pattern, and retreatment.
    Kim TH; Chang JM; Um SH; Jee H; Lee YR; Lee HA; Yim SY; Han NY; Lee JM; Choi HS; Kim ES; Yu YD; Keum B; Kim MJ; An H; Park BJ; Seo YS; Kim DS; Yim HJ; Cho SB; Jeen YT; Lee HS; Chun HJ; Kim YH; Kim CD
    Medicine (Baltimore); 2019 Jun; 98(26):e16279. PubMed ID: 31261600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
    Kagawa T; Koizumi J; Kojima S; Nagata N; Numata M; Watanabe N; Watanabe T; Mine T;
    Cancer; 2010 Aug; 116(15):3638-44. PubMed ID: 20564097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis.
    Dong W; Zhang T; Wang ZG; Liu H
    World J Gastroenterol; 2014 Aug; 20(29):10174-82. PubMed ID: 25110446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiofrequency ablation vs. surgical resection for resectable hepatocellular carcinoma: A systematic review and meta-analysis.
    Li JK; Liu XH; Cui H; Xie XH
    Mol Clin Oncol; 2020 Jan; 12(1):15-22. PubMed ID: 31814972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of radiofrequency ablation in the treatment of hepatocellular carcinoma.
    Feng K; Ma KS
    World J Gastroenterol; 2014 May; 20(20):5987-98. PubMed ID: 24876721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiofrequency ablation in the treatment of hepatocellular carcinoma.
    Deng Q; He M; Fu C; Feng K; Ma K; Zhang L
    Int J Hyperthermia; 2022; 39(1):1052-1063. PubMed ID: 35944905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes of laparoscopic radiofrequency ablation of single primary or recurrent hepatocellular carcinoma (≤3 cm).
    Na BG; Kim JM; Oh DK; Lee KW; Kang TW; Choi GS; Lee MW; Kwon CHD; Lim HC; Joh JW
    Ann Surg Treat Res; 2017 May; 92(5):355-360. PubMed ID: 28480181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma.
    Chong CC; Chan AW; Wong J; Chu CM; Chan SL; Lee KF; Yu SC; To KF; Johnson P; Lai PB
    Surgeon; 2018 Jun; 16(3):163-170. PubMed ID: 28807570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.